Loading clinical trials...
Loading clinical trials...
A Phase 2, Single-blind, Randomized, Controlled, Multi-center Study to Evaluate the Efficacy and Safety of SRM003 (Vascugel®) in Improving the Rate of Arteriovenous Fistula Maturation and Use in Subjects Undergoing Surgery for Creation of an Arteriovenous Fistula for Hemodialysis Access
Conditions
Interventions
SRM003
Participating Site's standard practice
Locations
47
United States
Akdhc Medical Research Services
Phoenix, Arizona, United States
Tucson Vascular Consultants
Tucson, Arizona, United States
Ladenheim Dialysis Access Center
Fresno, California, United States
California Institute of Renal Research
La Mesa, California, United States
VA Long Beach Health Care System Pharmacy
Long Beach, California, United States
The Regents University of California Los Angeles
Los Angeles, California, United States
Start Date
March 26, 2013
Primary Completion Date
October 27, 2014
Completion Date
October 27, 2014
Last Updated
June 8, 2021
NCT04634916
NCT06422845
NCT06527963
NCT04543539
NCT05418816
NCT07452822
Lead Sponsor
Shire
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions